You are considering a geographic expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy's marginal tax rate is 35%, their cost of capital is 15.7 % and an expected growth rate of 5% after 2003. 1999 15,000 5,500 100 2000 35,500 13,900 100 2001 46,000 18,000 100 5,300 5,400 17,200 6,020 11,180 100 11,280 (800) (1,267) 1998 8,500 3,100 100 2002 52,000 20,000 100 2003 60,000 24,000 100 Net Sales Cost of Sales Depreciation SG&A 3,500 1,100 700 245 5,410 2,800 1,190 417 6,400 4,100 11,000 3,850 7,150 100 7,250 (900) (2,457) 7,200 6,500 18,200 6,370 11,830 100 11,930 (300) (738) 7,800 7,000 21,100 7,385 13,715 100 13,815 (200) (912) R&D EBIT Taxes (35%) Net Income 455 774 Depreciation Operating Cash Flows CAPEX 100 100 555 874 (906) (2,030) (1,394) (780) Net Working Capital Terminal Value Free Cash Flows a) Calculate the free cash flows for 1998 – 2003 b) Calculate the terminal value of the Canopy project in 2003 and the adjusted free cash flow value for 2003. (HINT: Use the Gordon or Growing Perpetuity Model to calculate the terminal value).

Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
icon
Related questions
Question
**Title: Analyzing Incremental Cash Flows for Canopy Pharmaceuticals' European Market Expansion**

You are considering a geographic expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy’s marginal tax rate is 35%, their cost of capital is 15.7%, and an expected growth rate of 5% after 2003.

|            | 1998  | 1999  | 2000  | 2001  | 2002  | 2003  |
|------------|-------|-------|-------|-------|-------|-------|
| **Net Sales**      | 8,500 | 15,000| 35,500| 46,000| 52,000| 60,000|
| **Cost of Sales**  | 3,100 | 5,500 | 13,900| 18,000| 20,000| 24,000|
| **Depreciation**   | 100   | 100   | 100   | 100   | 100   | 100   |
| **SG&A**           | 3,500 | 5,410 | 6,400 | 5,300 | 7,200 | 7,800 |
| **R&D**            | 1,100 | 2,800 | 4,100 | 4,500 | 6,500 | 7,000 |
| **EBIT**           | 700   | 1,190 | 11,000| 17,200| 18,200| 21,100|
| **Taxes (35%)**    | 245   | 417   | 3,850 | 6,020 | 6,370 | 7,385 |
| **Net Income**     | 455   | 774   | 7,150 | 11,180| 11,830| 13,715|
| **Depreciation**   | 100   | 100   | 100   | 100   | 100   | 100   |
| **Operating Cash Flows** | 555 | 874   | 7,250 | 11,280| 11,930| 13,815|
| **CAPEX**          |
Transcribed Image Text:**Title: Analyzing Incremental Cash Flows for Canopy Pharmaceuticals' European Market Expansion** You are considering a geographic expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy’s marginal tax rate is 35%, their cost of capital is 15.7%, and an expected growth rate of 5% after 2003. | | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | |------------|-------|-------|-------|-------|-------|-------| | **Net Sales** | 8,500 | 15,000| 35,500| 46,000| 52,000| 60,000| | **Cost of Sales** | 3,100 | 5,500 | 13,900| 18,000| 20,000| 24,000| | **Depreciation** | 100 | 100 | 100 | 100 | 100 | 100 | | **SG&A** | 3,500 | 5,410 | 6,400 | 5,300 | 7,200 | 7,800 | | **R&D** | 1,100 | 2,800 | 4,100 | 4,500 | 6,500 | 7,000 | | **EBIT** | 700 | 1,190 | 11,000| 17,200| 18,200| 21,100| | **Taxes (35%)** | 245 | 417 | 3,850 | 6,020 | 6,370 | 7,385 | | **Net Income** | 455 | 774 | 7,150 | 11,180| 11,830| 13,715| | **Depreciation** | 100 | 100 | 100 | 100 | 100 | 100 | | **Operating Cash Flows** | 555 | 874 | 7,250 | 11,280| 11,930| 13,815| | **CAPEX** |
Expert Solution
Step 1

Finance homework question answer, step 1, image 1

steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Similar questions
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education